For more than 15 years, Eric has represented a diverse array of clients in IP-related matters, with an emphasis on strategic IP counseling, patent preparation and prosecution, IP due diligence and legal opinions.  

Eric also has substantial experience in patent litigation, providing a perspective that informs and enhances his other practice areas. In 2020 and 2021, Eric received the distinction of Best Lawyers in America^® for his patent law expertise. He was also recognized in 2020 by LMG Life Sciences as a Life Sciences Star for Patent Prosecution. Eric has also been named a Rising Star in Intellectual Property Law by Super Lawyers® since 2017.

With a technical background in molecular biology and biochemistry, Eric has represented both corporate and university clients in the biotechnology, pharmaceutical, bioprocessing and medical device areas.  Representative areas of technical focus include:

• therapeutic antibodies and other protein-based therapeutics,
• cancer detection, diagnosis and therapy,
• cancer immunotherapy, including CAR-T therapy,
• microRNAs and other non-coding RNAs,
• genome editing techniques, including CRISPR,
• vaccines and vaccine production,
• small molecule therapeutics, including enantiomers/diastereomers,
• immunological detection methods and assays,
• in situ hybridization probes and techniques,
• synthetic peptide compounds,
• PCR amplification and decontamination techniques,
• bioinformatics, including DNA sequencing methods and algorithms,
• protein engineering and redesign,
• natural product synthesis in plants and other hosts,
• transgenic mammals and plants,
• dialysis methods, systems and devices,
• aquaculture products and methods,
• filtration systems and processes, including tangential flow filtration.